Sort   by:  
 Page size 
UnknownRemote and in-clinic digital cognitive screening tools outperform the MoCA to distinguish cerebral amyloid status among cognitively healthy older adults.
Not available
S-EPMC10680059 | biostudies-literature
UnknownThe mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function.
Not available
S-EPMC4262609 | biostudies-literature
UnknownClinical and biomarker changes in dominantly inherited Alzheimer's disease.
Not available
S-EPMC3474597 | biostudies-literature
UnknownProfiling baseline performance on the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collection.
Not available
S-EPMC10806768 | biostudies-literature
UnknownPreclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial.
Not available
S-EPMC3880800 | biostudies-literature
UnknownStudy design and methods: U.S. study to protect brain health through lifestyle intervention to reduce risk (U.S. POINTER).
Not available
S-EPMC10916955 | biostudies-literature
UnknownPreclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.
Not available
S-EPMC6417794 | biostudies-literature
UnknownAdvancing combination therapy for Alzheimer's disease.
Not available
S-EPMC7539671 | biostudies-literature
UnknownClinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer's disease.
Not available
S-EPMC11227160 | biostudies-literature
UnknownAwareness of genetic risk in the Dominantly Inherited Alzheimer Network (DIAN).
Not available
S-EPMC7206736 | biostudies-literature
Sort   by:  
 Page size